• Profile
Close

Prostate-specific antigen parameters and prostate health index enhance prostate cancer prediction with the in-bore 3-T MRI-guided transrectal targeted prostate biopsy after negative 12-core biopsy

Urology Aug 31, 2017

Friedl A, et al. – This study was conducted to evaluate prostate cancer (PCa) detection and prediction by combining the in–bore MRI–guided transrectal targeted prostate biopsy (MRGB) with prostate–specific antigen (PSA) parameters and the prostate health index (PHI) in case of negative 12–core standard biopsy (SB). Following negative SB of the prostate, it was noted that the MRGB achieved an overall prostate cancer (PCa) detection rate of 55% in patients with prostate imaging reporting and data system (PI–RADS) 3 to 5 lesions. By considering PHI and PHI density (PHID) 82%/62% of unnecessary biopsies could have been avoided, failing to detect 31%/16% cancers.

Methods
  • In this research, a sum of 112 males (2014–2016) underwent 3.0T multi–parametric MRI (mpMRI) and subsequent MRGB of Prostate Imaging Reporting and Data System (PI–RADS) lesions 3–5.
  • They noted ancillary PSA parameters (PSA ratio [%fPSA], PSA density [PSAD]) and the PHI and PHI density (PHID).
  • Thereafter, with these parameters in combination with MRGB PCa prediction was computed.

Results
  • As evidence accumulates, the most common lesions biopsied were PI–RADS 4 (66%), in the peripheral zone (64%), in the mid (58%) and anterior (65%) section of the prostate and 13 (IQR 10–15) mm large.
  • They found PCa was in 62 (55%) patients (28% Gleason Score ≥7). PSAD (0.15 vs. 0.21; p=0.0051), %fPSA (16 vs. 13; p=0.0191), PHI (45 vs. 69; p<0.0001), PHID (0.7 vs. 1.5; p<0.0001) and prostate volume (ml; 56 vs. 45; p=0.0073) were significantly different in patients without/with PCa.
  • It was showed that PHI and PHID were the strongest predictors of PCa with an AUC of 0.79 and 0.77, respectively.
  • Applying optimal thresholds of 59 and 0.79, they illustrated that PHI and PHID were 69%/84% sensitive and 82%/62% specific for PCa.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay